The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.
COVID-19, SARS and MERS: are they closely related?
Open accessAbstract
Background The 2019 novel coronavirus (SARS-CoV-2) is a new human coronavirus which is spreading with epidemic features in China and other Asian countries; cases have also been reported worldwide. This novel coronavirus disease (COVID-19) is associated with a respiratory illness that may lead to severe pneumonia and acute respiratory distress syndrome (ARDS). Although related to the severe acute respiratory syndrome (SARS) and the Middle East respiratory syndrome (MERS), COVID-19 shows some peculiar pathogenetic, epidemiological and clinical features which to date are not completely understood. Aims To provide a review of the differences in pathogenesis, epidemiology and clinical features of COVID-19, SARS and MERS. Sources The most recent literature in the English language regarding COVID-19 has been reviewed, and extracted data have been compared with the current scientific evidence about SARS and MERS epidemics. Content COVID-19 seems not to be very different from SARS regarding its clinical features. However, it has a fatality rate of 2.3%, lower than that of SARS (9.5%) and much lower than that of MERS (34.4%). The possibility cannot be excluded that because of the less severe clinical picture of COVID-19 it can spread in the community more easily than MERS and SARS. The actual basic reproductive number (R 0 ) of COVID-19 (2.0–2.5) is still controversial. It is probably slightly higher than the R 0 of SARS (1.7–1.9) and higher than that of MERS (<1). A gastrointestinal route of transmission for SARS-CoV-2, which has been assumed for SARS-CoV and MERS-CoV, cannot be ruled out and needs further investigation. Implications There is still much more to know about COVID-19, especially as concerns mortality and its capacity to spread on a pandemic level. Nonetheless, all of the lessons we learned in the past from the SARS and MERS epidemics are the best cultural weapons with which to face this new global threat.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., et al. (2020) · JAMA · doi:10.1001/jama.2020.1585 · Cited by 20,148
La certeza de lo impredecible: Cultura Educación y Sociedad en tiempos de COVID19
Martínez González, M. (2020) · DSPACE System - Metalibrary (University of the Coast) · Cited by 18,463
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
Chan, J. F.-W., Yuan, S., Kok, K.-H., To, K. K.-W., Chu, H., Yang, J., Xing, F., Liu, J., Yip, C. C.-Y., Poon, R. W.-S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30154-9 · Cited by 8,944
First case of 2019 novel coronavirus in the United States
Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001191 · Cited by 6,030
Hamming, I., Timens, W., Bulthuis, M., Lely, A., Navis, G., & van Goor, H. (2004) · The Journal of Pathology · doi:10.1002/path.1570 · Cited by 5,676 · cited 6×
“Coronavirus disease (COVID-19) is the clinical syndrome associated with SARS-CoV-2 infection; it is characterized by a respiratory syndrome with a variable degree of severity, ranging from a mild upper respiratory tract illness to severe interstitial pneumonia and acute respiratory distress syndrome (ARDS) [2e4].”
Influential
Cited by
Rogers, J. P., Chesney, E., Oliver, D., Pollak, T. A., McGuire, P., Fusar-Poli, P., Zandi, M. S., Lewis, G., & David, A. S. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30203-0 · Cited by 2,407
The cytokine storm and COVID-19
Hu, B., Huang, S., & Yin, L. (2021) · Journal of Medical Virology · doi:10.1002/jmv.26232 · Cited by 1,655
Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase
Wang, Q., Wu, J., Wang, H., Gao, Y., Liu, Q., Mu, A., Ji, W., Yan, L., Zhu, Y., Zhu, C., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.034 · Cited by 776
The SARS-CoV-2 main protease as drug target
Ullrich, S., & Nitsche, C. (2020) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2020.127377 · Cited by 772
The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis
Deng, J., Zhou, F., Hou, W., Silver, Z., Wong, C. Y., Chang, O., Huang, E., & Zuo, Q. K. (2021) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14506 · Cited by 771
Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis
Madewell, Z. J., Yang, Y., Longini, I. M., Halloran, M. E., & Dean, N. E. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.31756 · Cited by 716
COVID-19: A Global Challenge with Old History, Epidemiology and Progress So Far
Khan, M., Adil, S. F., Alkhathlan, H. Z., Tahir, M. N., Saif, S., Khan, M., & Khan, S. T. (2020) · Molecules · doi:10.3390/molecules26010039 · Cited by 584
Nearchou, F., Flinn, C., Niland, R., Subramaniam, S. S., & Hennessy, E. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17228479 · Cited by 577
“Although comparisons have been made between this novel coronavirus and the 2003 severe acute respiratory syndrome (SARS), it has been suggested that due to the less severe clinical picture of COVID-19, the virus can spread more easily in the community than either SARS or Middle East Respiratory Syndrome (MERS) [2].”
BackgroundInfluentialA comprehensive review of COVID-19 characteristics
Esakandari, H., Nabi-Afjadi, M., Fakkari-Afjadi, J., Farahmandian, N., Miresmaeili, S.-M., & Bahreini, E. (2020) · Biological Procedures Online · doi:10.1186/s12575-020-00128-2 · Cited by 510
Recent Developments on Therapeutic and Diagnostic Approaches for COVID-19
Majumder, J., & Minko, T. (2021) · The AAPS Journal · doi:10.1208/s12248-020-00532-2 · Cited by 505
Shi, S., Qin, M., Cai, Y., Liu, T., Shen, B., Yang, F., Cao, S., Liu, X., Xiang, Y., Zhao, Q., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa408 · Cited by 484
Habibi-Yangjeh, A., Asadzadeh-Khaneghah, S., Feizpoor, S., & Rouhi, A. (2020) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2020.07.047 · Cited by 473
Baj, J., Karakuła-Juchnowicz, H., Teresiński, G., Buszewicz, G., Ciesielka, M., Sitarz, R., Forma, A., Karakuła, K., Flieger, W., Portincasa, P., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9061753 · Cited by 453
Jones, D. L., Baluja, M. Q., Graham, D. W., Corbishley, A., McDonald, J. E., Malham, S. K., Hillary, L. S., Connor, T. R., Gaze, W. H., Moura, I. B., et al. (2020) · Science of The Total Environment · doi:10.1016/j.scitotenv.2020.141364 · Cited by 397
Iaccarino, G., Grassi, G., Borghi, C., Ferri, C., Salvetti, M., Volpe, M., Cicero, A. F. G., Minuz, P., Muiesan, M. L., Mulatero, P., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15324 · Cited by 392
MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells
Yin, X., Riva, L., Pu, Y., Martin-Sancho, L., Kanamune, J., Yamamoto, Y., Sakai, K., Gotoh, S., Miorin, L., De Jesus, P. D., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2020.108628 · Cited by 383
COVID-19: Virology, biology and novel laboratory diagnosis
Mohamadian, M., Chiti, H., Shoghli, A., Biglari, S., Parsamanesh, N., & Esmaeilzadeh, A. (2021) · The Journal of Gene Medicine · doi:10.1002/jgm.3303 · Cited by 371
Serial interval and incubation period of COVID-19: a systematic review and meta-analysis
Alene, M., Yismaw, L., Assemie, M. A., Ketema, D. B., Gietaneh, W., & Birhan, T. Y. (2021) · BMC Infectious Diseases · doi:10.1186/s12879-021-05950-x · Cited by 354
Alimohamadi, Y., Sepandi, M., Taghdir, M., & Hosamirudsari, H. (2020) · Journal of preventive medicine and hygiene · doi:10.15167/2421-4248/jpmh2020.61.3.1530 · Cited by 345
Jafarzadeh, A., Chauhan, P., Saha, B., Jafarzadeh, S., & Nemati, M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118102 · Cited by 327
COVID-19 Transmission, Current Treatment, and Future Therapeutic Strategies
Salian, V. S., Wright, J. A., Vedell, P. T., Nair, S., Li, C., Kandimalla, M., Tang, X., Carmona Porquera, E. M., Kalari, K. R., & Kandimalla, K. K. (2021) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00608 · Cited by 315
ACE2: Evidence of role as entry receptor for SARS-CoV-2 and implications in comorbidities
Zamorano Cuervo, N., & Grandvaux, N. (2020) · eLife · doi:10.7554/elife.61390 · Cited by 313
An aberrant STAT pathway is central to COVID-19
Matsuyama, T., Kubli, S. P., Yoshinaga, S. K., Pfeffer, K., & Mak, T. W. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-020-00633-7 · Cited by 289
COVID–19-associated coagulopathy: An exploration of mechanisms
Colling, M. E., & Kanthi, Y. (2020) · Vascular Medicine · doi:10.1177/1358863x20932640 · Cited by 278
Faisal, R. A., Jobe, M. C., Ahmed, O., & Sharker, T. (2022) · International Journal of Mental Health and Addiction · doi:10.1007/s11469-020-00458-y · Cited by 275
The role of IL-6 and other mediators in the cytokine storm associated with SARS-CoV-2 infection
Copaescu, A., Smibert, O., Gibson, A., Phillips, E. J., & Trubiano, J. A. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.07.001 · Cited by 262
Preliminary predictive criteria for COVID-19 cytokine storm
Caricchio, R., Gallucci, M., Dass, C., Zhang, X., Gallucci, S., Fleece, D., Bromberg, M., & Criner, G. J. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2020-218323 · Cited by 230
Nchioua, R., Kmiec, D., Müller, J. A., Conzelmann, C., Groß, R., Swanson, C. M., Neil, S. J. D., Stenger, S., Sauter, D., Münch, J., et al. (2020) · mBio · doi:10.1128/mbio.01930-20 · Cited by 146
Clinical characteristics and in-hospital mortality of COVID-19 adult patients in Saudi Arabia
Abohamr, S. I., Abazid, R. M., Aldossari, M. A., Amer, H. A., Badhawi, O. S., Aljunaidi, O. M., Alzarzour, S. H., Saadeddin, H. M., Bhat, F. A., & Elsheikh, E. (2020) · Saudi Medical Journal · doi:10.15537/smj.2020.11.25495 · Cited by 57
Cao, L., & Liu, Q. (2022) · doi:10.1101/2022.08.22.22279022 · Cited by 49
What can psychiatrists learn from SARS and MERS outbreaks?
Sommer, I. E., & Bakker, P. R. (2020) · The Lancet Psychiatry · doi:10.1016/s2215-0366(20)30219-4 · Cited by 44
Potential Role for Herpesviruses in Alzheimer’s Disease
Duggan, M. R., Torkzaban, B., Ahooyi, T. M., & Khalili, K. (2020) · Journal of Alzheimer's Disease · doi:10.3233/jad-200814 · Cited by 13
Metadata
- Authors
- Petrosillo, N., Viceconte, G., Ergonul, O., Ippolito, G., & Petersen, E.
- Venue
- Clinical Microbiology and Infection
- Publisher
- Elsevier BV
- Published
- 2020-06
- Volume
- 26
- Issue
- 6
- Pages
- 729-734
- ISSN
- 1198-743X (ISSN-L)
- OpenAlex
- W3013008917
- Cited by
- 1,108
- References
- 53
- FWCI
- 30.48
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.